Martín A. Rivas

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	2827	1708
h-endeksi	23	17
i10-endeksi	26	24

420

210

105

315

2009201020112012201320142015201620172018201920202021202220232024202518 19 33 78 80 83 100 110 159 158 256 314 407 322 298 304 63

Genel erişim

Tümünü görüntüle

20 makale

0 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Wendy BéguelinAssistant Professor, Weill Cornell Medicinemed.cornell.edu üzerinde doğrulanmış e-posta adresine sahip
Cecilia Jazmín ProiettiPhD, Associate Investigator, Institute of Biology & Experimental Medicineibyme.conicet.gov.ar üzerinde doğrulanmış e-posta adresine sahip
Cinthia RosemblitBIOMED - UCA - CONICETuca.edu.ar üzerinde doğrulanmış e-posta adresine sahip
Mercedes TkachInsitut Curiecurie.fr üzerinde doğrulanmış e-posta adresine sahip
Maria Celeste Diaz FlaqueDra.uca.edu.ar üzerinde doğrulanmış e-posta adresine sahip
Ari MelnickProfessor of Medicine, Weill Cornell Medicinemed.cornell.edu üzerinde doğrulanmış e-posta adresine sahip
Olivier ElementoDirector, Englander Institute for Precision Medicine, Weill Cornell Medicinemed.cornell.edu üzerinde doğrulanmış e-posta adresine sahip
Violeta Serra, PhDPrincipal Investigatorvhio.net üzerinde doğrulanmış e-posta adresine sahip
María Florencia MercoglianoIBYME-CONICETibyme.org.ar üzerinde doğrulanmış e-posta adresine sahip
Maria T. Calvo FernandezMemorial Sloan Kettering Cancer Center (NY)mskcc.org üzerinde doğrulanmış e-posta adresine sahip
Cem MeydanWeill Cornell Medical Collegemed.cornell.edu üzerinde doğrulanmış e-posta adresine sahip
Florencia CayrolInstituto de Investigciones Biomédicas-UCA -CONICETuca.edu.ar üzerinde doğrulanmış e-posta adresine sahip
Christopher MasonWorldQuant Professor of Genomics, Physiology, & Biophysics, Weill Cornell Medicinemed.cornell.edu üzerinde doğrulanmış e-posta adresine sahip
JUAN CARLOS ROAPONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Professor and Chair Department of Pathology.med.puc.cl üzerinde doğrulanmış e-posta adresine sahip
Aaron D VinyAssistant Professor of Medicine, Departments of Genetics & Development and Medicine, Division ofcumc.columbia.edu üzerinde doğrulanmış e-posta adresine sahip
Mara De MartinoWeill Cornell Medical Collegemed.cornell.edu üzerinde doğrulanmış e-posta adresine sahip
Franco IzzoAssistant Professor, Icahn School of Medicine at Mount Sinaiibyme.conicet.gov.ar üzerinde doğrulanmış e-posta adresine sahip
Christopher LordProfessor of Cancer Genomics, Institute of Cancer Research, London, UKicr.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Yanwen JiangInstructor, Weill Cornell Medical College of Cornell Universitymed.cornell.edu üzerinde doğrulanmış e-posta adresine sahip
Sapia SandraWeill Cornell Medicine - Qatar / Sidra Medicine - Qatarqatar-med.cornell.edu üzerinde doğrulanmış e-posta adresine sahip

Takip et

Martín A. Rivas

University of Miami Miller School of Medicine

med.miami.edu üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa

Molecular oncology B- cell lymphoma cohesin chromosomal architecture breast cancer


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Early adaptation and acquired resistance to CDK4/6 inhibition in estrogen receptor–positive breast cancer MT Herrera-Abreu, M Palafox, U Asghar, MA Rivas, RJ Cutts, ... Cancer research 76 (8), 2301-2313, 2016	733	2016
TNFα acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-κB-dependent pathways MA Rivas, RP Carnevale, CJ Proietti, C Rosemblit, W Beguelin, ... Experimental cell research 314 (3), 509-529, 2008	216	2008
EZH2 enables germinal centre formation through epigenetic silencing of CDKN1A and an Rb-E2F1 feedback loop W Béguelin, MA Rivas, MT Calvo Fernández, M Teater, A Purwada, ... Nature communications 8 (1), 877, 2017	183	2017
TET2 deficiency causes germinal center hyperplasia, impairs plasma cell differentiation, and promotes B-cell lymphomagenesis PM Dominguez, H Ghamlouch, W Rosikiewicz, P Kumar, W Béguelin, ... Cancer discovery 8 (12), 1632-1653, 2018	166	2018
Dose-dependent role of the cohesin complex in normal and malignant hematopoiesis AD Viny, CJ Ott, B Spitzer, M Rivas, C Meydan, E Papalexi, D Yelin, ... Journal of Experimental Medicine 212 (11), 1819-1832, 2015	165	2015
Mutant EZH2 induces a pre-malignant lymphoma niche by reprogramming the immune response W Béguelin, M Teater, C Meydan, KB Hoehn, JM Phillip, AA Soshnev, ... Cancer cell 37 (5), 655-673. e11, 2020	136	2020
TNFα-induced mucin 4 expression elicits trastuzumab resistance in HER2-positive breast cancer MF Mercogliano, M De Martino, L Venturutti, MA Rivas, CJ Proietti, ... Clinical Cancer Research 23 (3), 636-648, 2017	119	2017
Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3 W Béguelin, MC Díaz Flaqué, CJ Proietti, F Cayrol, MA Rivas, M Tkach, ... Molecular and cellular biology 30 (23), 5456-5472, 2010	119	2010
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development MA Rivas, L Venturutti, YW Huang, R Schillaci, THM Huang, PV Elizalde Breast cancer research 14, 1-21, 2012	117	2012
p42/p44 MAPK-mediated Stat3 Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth M Tkach, C Rosemblit, MA Rivas, CJ Proietti Anastasi, MC Díaz Flaqué, ... Bioscientifica, 2013	108	2013
MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1 L Venturutti, RI Cordo Russo, MA Rivas, MF Mercogliano, F Izzo, ... Oncogene 35 (48), 6189-6202, 2016	91	2016
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization AP Gomes, D Ilter, V Low, A Rosenzweig, ZJ Shen, T Schild, MA Rivas, ... Cancer Cell 36 (4), 402-417. e13, 2019	88	2019
Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth CJ Proietti, C Rosemblit, W Beguelin, MA Rivas, MC Díaz Flaqué, ... Molecular and cellular biology 29 (5), 1249-1265, 2009	73	2009
Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells M Tkach, L Coria, C Rosemblit, MA Rivas, CJ Proietti, MC Díaz Flaqué, ... The Journal of Immunology 189 (3), 1162-1172, 2012	59	2012
BCL6 antagonizes NOTCH2 to maintain survival of human follicular lymphoma cells E Valls, C Lobry, H Geng, L Wang, M Cardenas, M Rivas, L Cerchietti, ... Cancer discovery 7 (5), 506-521, 2017	54	2017
Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model T Durfort, M Tkach, MI Meschaninova, MA Rivas, PV Elizalde, ... PLoS One 7 (1), e29213, 2012	54	2012
Immunization with murine breast cancer cells treated with antisense oligodeoxynucleotides to type I insulin-like growth factor receptor induced an antitumoral effect mediated … R Schillaci, M Salatino, J Cassataro, CJ Proietti, GH Giambartolomei, ... The Journal of Immunology 176 (6), 3426-3437, 2006	48	2006
Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer … MC Díaz Flaqué, NM Galigniana, W Béguelin, R Vicario, CJ Proietti, ... Breast Cancer Research 15, 1-24, 2013	47	2013
Transactivation of ErbB-2 induced by tumor necrosis factor α promotes NF-κB activation and breast cancer cell proliferation MA Rivas, M Tkach, W Beguelin, CJ Proietti, C Rosemblit, EH Charreau, ... Breast Cancer Research and Treatment 122 (1), 111-124, 2010	44	2010
Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation MA Rivas, C Meydan, CR Chin, MF Challman, D Kim, B Bhinder, ... Nature immunology 22 (2), 240-253, 2021	39	2021

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar